Announcements Trials
Browse Landscape

Phase

Phase 3 1Phase 2 1Phase 1/2 1

Status

Withdrawn 1Unknown 1Terminated 1

Sponsor Class

OTHER 114NETWORK 9NIH 3INDUSTRY 3UNKNOWN 1FED 1

Study Type

Interventional 3

Sponsor

Cancer Type

Thoracic 3

Conditions

Prostatic Neoplasms 3Carcinoma, Non-Small-Cell Lung 3Brain Neoplasms 3Neoplasms 2Neoplasm Metastasis 2Melanoma 2Glioblastoma 2Colorectal Neoplasms 2Triple Negative Breast Neoplasms 1Squamous Cell Carcinoma of Head and Neck 1Recurrence 1Prostate Adenocarcinoma 1Parkinson Disease 4, Autosomal Dominant Lewy Body 1Pancreatic Neoplasms 1Ovarian Neoplasms 1Lymphoma, Non-Hodgkin 1Lung Neoplasms 1Liver Neoplasms 1Gliosarcoma 1Glioma 1Central Nervous System Neoplasms 1Carcinoma, Transitional Cell 1Carcinoma, Merkel Cell 1Brain Diseases 1Adenocarcinoma 1

Interventions

Carboplatin 364Pemetrexed 308pembrolizumab 300Cisplatin 240Paclitaxel 230Docetaxel 199Gemcitabine 130Nivolumab 121Erlotinib Hydrochloride 114Bevacizumab 85osimertinib 77atezolizumab 65durvalumab 58Cetuximab 57130-nm albumin-bound paclitaxel 56Gefitinib 52Ipilimumab 46Afatinib 38Drug Therapy 33Cyclophosphamide 30Crizotinib 30Albumin-Bound Paclitaxel 30Vinorelbine 28cemiplimab 26tislelizumab 25avelumab 23icotinib 22Radiotherapy 22capmatinib 21Oxaliplatin 21

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

3 trials
RecentStart dateEnrollment
INDUSTRY × Carcinoma, Non-Small-Cell Lung × Radiosurgery × Clear all
NCT03924869 2025-12-11

KEYNOTE-867

Merck Sharp & Dohme LLC

Phase 3 Terminated
448 enrolled 24 charts
Thoracic

Parkinson Disease 4, Autosomal Dominant Lewy Body, Carcinoma, Non-Small-Cell Lung

NCT03169738 2025-02-21

QUILT-3.044: NANT Non-small Cell Lung Cancer (NSCLC) Vaccine: Combination Immunotherapy in Subjects With NSCLC Who Have Progressed After Treatment With PD-1/PD-L1 Inhibitors

ImmunityBio, Inc.

Phase 1/2 Withdrawn
Thoracic

Carcinoma, Non-Small-Cell Lung

NCT00643318 2021-03-05

CyberKnife Radiosurgical Treatment of Inoperable Early Stage Non-Small Cell Lung Cancer

Accuray Incorporated

Phase 2 Unknown
40 enrolled
Thoracic

Carcinoma, Non-Small-Cell Lung, Lung Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡